TGFB1 and telomere syndrome: The NF-κB and TGF-β pathways have been described to influence the prognosis in several types of STS, including malignant fibrous histiocytoma, Ewing sarcoma, osteosarcoma and rhabdomyosarcoma [17]–[21].